| Autor: |
Fallin, Taylor, Thacker, Erica, Sahra, Syeda, Siegrist, Emily A., White, Bryan P., Summers, Katherine, Shibib, Dena, Sassine, Joseph |
| Předmět: |
|
| Zdroj: |
Journal of Pharmacy Practice; Dec2024, Vol. 37 Issue 6, p1391-1395, 5p |
| Abstrakt: |
Bruton's tyrosine kinase inhibitors (BTKis) are the preferred treatment for chronic lymphocytic leukemia (CLL). Despite their therapeutic benefits, these targeted agents have been associated with an increased risk of invasive infections. We describe a 68-year-old male who developed multiple bacterial, fungal and viral infections while on treatment with acalabrutinib. To our knowledge, this is the first reported case of concomitant CNS infections with Cryptococcus neoformans and Aspergillus fumigatus, along with cytomegalovirus (CMV) and herpes simplex virus type 1 (HSV-1) pneumonia while on acalabrutinib. This case adds to the scarce literature of fungal and bacterial infections associated with acalabrutinib, raising the suspicion that infection risk is a medication class effect for BTKis. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
